Suppr超能文献

多胺生物合成抑制剂对小鼠黑色素瘤细胞生长和黑色素生成的影响。

Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells.

作者信息

Käpyaho K, Sinervirta R, Jänne J

出版信息

Cancer Res. 1985 Apr;45(4):1444-8.

PMID:3919940
Abstract

Both 2-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (EC 4.1.1.17), and methylglyoxal bis(guanylhydrazone) (MGBG), a competitive inhibitor of S-adenosylmethionine decarboxylase (EC 4.1.1.50), strikingly stimulated melanotic expression of murine Cloudman S91 melanoma cells. The stimulation of tyrosinase (EC 1.10.3.1) activity and melanin formation by DFMO was closely associated with intracellular depletion of putrescine and spermidine developed in response to the drug. However, little or no evidence was obtained indicating that enhanced melanogenesis in response to MGBG was mediated through an inhibition of polyamine biosynthesis. Indirect inhibitors of ornithine decarboxylase, such as 1,3-diaminopropane and 1,3-diaminopropan-2-ol, but not putrescine, likewise inhibited the growth of the melanoma cells and stimulated their melanin production. The stimulation of melanogenesis by polyamine antimetabolites was not mediated by cyclic adenosine 3':5'-monophosphate, in contrast to the effect elicited by alpha-melanotropin. It is also unlikely that MGBG or the diamines acted as lysosomotropic agents capable of stimulating tyrosinase activity in situ, since the enzyme activity was stimulated by the drugs irrespective of whether assayed in cultured cells or using cell-free homogenates. None of the agents stimulated tyrosinase activity in vitro. The effect of DFMO and MGBG on melanoma cell proliferation was reversible, but the restoration of normal growth and melanin formation, especially in cells exposed to DFMO, was remarkably slow. The present results represent a further experimental model, in which the inhibition of polyamine accumulation is accompanied by signs of terminal differentiation.

摘要

鸟氨酸脱羧酶(EC 4.1.1.17)的不可逆抑制剂2-二氟甲基鸟氨酸(DFMO)和S-腺苷甲硫氨酸脱羧酶(EC 4.1.1.50)的竞争性抑制剂甲基乙二醛双(脒腙)(MGBG)均显著刺激小鼠Cloudman S91黑色素瘤细胞的黑色素生成。DFMO对酪氨酸酶(EC 1.10.3.1)活性和黑色素形成的刺激与药物引起的细胞内腐胺和亚精胺耗竭密切相关。然而,几乎没有证据表明MGBG诱导的黑色素生成增强是通过抑制多胺生物合成介导的。鸟氨酸脱羧酶的间接抑制剂,如1,3-二氨基丙烷和1,3-二氨基丙-2-醇,但不是腐胺,同样抑制黑色素瘤细胞的生长并刺激其黑色素生成。与α-促黑素细胞激素引起的效应相反,多胺抗代谢物对黑色素生成的刺激不是由环磷酸腺苷介导的。MGBG或二胺也不太可能作为能够原位刺激酪氨酸酶活性的溶酶体亲和剂,因为无论在培养细胞中还是使用无细胞匀浆进行测定,药物均能刺激该酶活性。这些试剂在体外均未刺激酪氨酸酶活性。DFMO和MGBG对黑色素瘤细胞增殖的影响是可逆的,但恢复正常生长和黑色素形成,尤其是在暴露于DFMO的细胞中,非常缓慢。目前的结果代表了另一个实验模型,其中多胺积累的抑制伴随着终末分化的迹象。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验